Movano (NASDAQ:MOVE) Now Covered by Analysts at Benchmark

Benchmark assumed coverage on shares of Movano (NASDAQ:MOVE) in a research report released on Tuesday, MarketBeat Ratings reports. The firm issued a speculative buy rating and a $2.00 price target on the technology company’s stock.

Movano Stock Performance

NASDAQ MOVE opened at $0.37 on Tuesday. Movano has a 12 month low of $0.24 and a 12 month high of $1.45. The company’s 50 day moving average is $0.37 and its two-hundred day moving average is $0.48.

Movano (NASDAQ:MOVE) last announced its quarterly earnings data on Wednesday, May 15th. The technology company reported ($0.10) EPS for the quarter. The firm had revenue of $0.85 million for the quarter.

Hedge Funds Weigh In On Movano

Institutional investors and hedge funds have recently made changes to their positions in the business. EP Wealth Advisors LLC bought a new position in shares of Movano in the 4th quarter valued at about $101,000. Mirador Capital Partners LP lifted its stake in shares of Movano by 9.6% in the 1st quarter. Mirador Capital Partners LP now owns 413,204 shares of the technology company’s stock valued at $170,000 after purchasing an additional 36,230 shares during the last quarter. Finally, Quantum Private Wealth LLC boosted its holdings in shares of Movano by 113.8% in the 2nd quarter. Quantum Private Wealth LLC now owns 89,139 shares of the technology company’s stock worth $25,000 after purchasing an additional 47,441 shares during the period. 16.64% of the stock is owned by hedge funds and other institutional investors.

Movano Company Profile

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.